Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic

This publication has 8 references indexed in Scilit:

• Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
  Emerging Infectious Diseases, 2021
• Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
  Nature Metabolism, 2021
• SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids—An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis
  Journal of Maxillofacial and Oral Surgery, 2021
• Dexamethasone in Hospitalized Patients with Covid-19
  New England Journal of Medicine, 2021
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
  JAMA, 2020
• Diabetes and mucormycosis: A complex interplay
  Diabetes & Metabolism, 2012
• The role of iron and iron chelators in zygomycosis
  Clinical Microbiology and Infection, 2009
• The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus
  Medical Mycology, 2006